Story thread · 3 reports / 3 sources
UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy
endpts.com · 12d
How the coverage leans
Across 3 sources · syndicated copies counted once
Plus, news about Regeneron, Novocure, Jazz's Ziihera, BioMarin, Ascendis, AstraZeneca, Hutchmed and TScan Therapeutics. Another road bump for Tavneos: The Medicines and Healthcare products Regulatory Agency (MHRA) has followed the EMA’s lead ...
First report: UK regulator suspends Amgen rare-disease drug Tavneos for new patients — investing.com, 13d
The coverage
- Amgen slapped with U.K. suspension of rare-disorder therapy Tavneos
seekingalpha.com · 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.